Treatment for Adult Growth Hormone Deficiency

Treatment for AGHD

Recombinant human GH (rhGH) is administered by once daily subcutaneous injections in a fashion very similar to the way in which a diabetic patient self-administers insulin. Patients are often started on a low initial dose, with dose increases based on clinical response and serum IGF-1 levels adjusted to the mid-normal range for age and gender. GH therapy has been shown to improve lean body mass, bone density, exercise tolerance, personal productivity and quality of life. The most common side effects are fluid retention and muscle/joint aches. These side effects are largely dose related, and these symptoms can be minimized by starting with a low initial dose and/or dose reductions.